(1)
Stein-Gold, L.; Elewski, B.; Draelos, Z.; Lin, T. Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis. J of Skin 2020, 4, S9.